StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
AstraZeneca (AZN) Shares Decline After Recruitment Paused in Head and Neck Cancer Trial
October 27, 2016 10:58 AM
(Updated - October 27, 2016 11:44 AM EDT)(Updated - October 27, 2016 11:13 and 11:27 AM EDT)AstraZeneca (NYSE: AZN) declined ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Hot Corp. News
Hot FDA News
Trader Talk
Next Articles
Jefferies Raises Price Target on Bristol-Myers Squibb (BMY) Following 3Q
October 28, 2016 8:00 AM
AstraZeneca (AZN) Confirms FDA Partial Clinical Hold Placed on Patient Recruitment for MEDI4736 Trial in HNSCC; Issues Commentary
October 27, 2016 2:47 PM